These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. Casey DE. J Clin Psychiatry; 1998; 59 Suppl 3():31-7. PubMed ID: 9541336 [Abstract] [Full Text] [Related]
3. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Meltzer HY, Okayli G. Am J Psychiatry; 1995 Feb; 152(2):183-90. PubMed ID: 7840350 [Abstract] [Full Text] [Related]
4. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. Meltzer HY. J Clin Psychiatry; 1999 Feb; 60 Suppl 12():47-50. PubMed ID: 10372612 [Abstract] [Full Text] [Related]
5. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A. J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [Abstract] [Full Text] [Related]
6. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. Meltzer HY. J Clin Psychiatry; 2005 Apr; 66(4):530-3. PubMed ID: 15816797 [No Abstract] [Full Text] [Related]
7. Clozapine: current status and role in the pharmacotherapy of schizophrenia. Remington GJ, Addington D, Collins EJ, Jones BD, Lalonde P, MacCrimmon DJ, MacEwan GW. Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645 [Abstract] [Full Text] [Related]
8. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients? Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R. J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492 [Abstract] [Full Text] [Related]
10. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug. Li CR, Chung YC, Park TW, Yang JC, Kim KW, Lee KH, Hwang IK. World J Biol Psychiatry; 2009 Jul; 10(4 Pt 3):919-24. PubMed ID: 19995222 [Abstract] [Full Text] [Related]
11. [Retrospective study of clozapine use in Ile-de-France]. Hiltgen S, Mantelet S, Pinabel F, Enjaume F. Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592 [Abstract] [Full Text] [Related]
12. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Duggan A, Warner J, Knapp M, Kerwin R. Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341 [Abstract] [Full Text] [Related]
13. Treatment-resistant schizophrenia--the role of clozapine. Meltzer HY. Curr Med Res Opin; 1997 Jun; 14(1):1-20. PubMed ID: 9524789 [Abstract] [Full Text] [Related]
14. New drugs for the treatment of schizophrenia. Meltzer HY. Psychiatr Clin North Am; 1993 Jun; 16(2):365-85. PubMed ID: 8101373 [Abstract] [Full Text] [Related]
15. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group. Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175 [Abstract] [Full Text] [Related]
17. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Kane JM. Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888 [Abstract] [Full Text] [Related]
18. The effect of clozapine on preexisting tardive dyskinesia. Littrell K, Magill AM. J Psychosoc Nurs Ment Health Serv; 1993 Sep; 31(9):14-8. PubMed ID: 7901407 [Abstract] [Full Text] [Related]
19. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D. Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566 [Abstract] [Full Text] [Related]